1 |
Coppola G, Mangano S, Tortorella G, Pelliccia A, Fels A, Romano A, et al. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res 2004;59:35-42.
DOI
ScienceOn
|
2 |
Shorvon SD. Medical assesment and treatment of chronic epilepsy. BMJ 1991;302:363-6.
DOI
ScienceOn
|
3 |
Vigevano F. Levetiracetam in pediatrics. J Child Neurol 2005; 20:87-93.
DOI
ScienceOn
|
4 |
Lynch BA, Lambeng N, Nocka K. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101:9861-6.
DOI
ScienceOn
|
5 |
Otoul C, Smedt HD, Stockis A. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Epilepsia 2007;48:2111-5.
DOI
ScienceOn
|
6 |
Perry MS, Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years: A retrospective review. Epilepsia 2007;48:1123-7.
DOI
ScienceOn
|
7 |
Striano P, Coppola A, Pezzella M, Ciampa C, Specchio N, Ragona F, et al. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 2007;69:250- 4.
DOI
ScienceOn
|
8 |
Barron TF, Faircloth VC, Yuncker LA, Hunt SL. Levetiracetam adjunctive therapy for refractory pediatric generalized epilepsies. Epilepsia 2001;42(7 Suppl):S53.
|
9 |
Buyse G, Ceulemans B, Lagae L. Add-on levetiracetam on refractory generalized childhood epilepsy syndromes. Epilepsia 2002;43(8 Suppl):S154.
DOI
ScienceOn
|
10 |
Berg J, Wruk M, Baeumel C, Kluger G, Holthausen H. Addon therapy with levetiracetam in difficult-to-treat, idiopathic focal epilepsies of childhood. Epilepsia 2003;44(8 Suppl):S79.
DOI
ScienceOn
|
11 |
Mikati MA, Banna DEI, Sinno D, Mroueh S. Response of infantile spasms to levetiracetam. Neurology 2008;70:574-5.
DOI
ScienceOn
|
12 |
Pina-Garza JE, Nordli DR, Rating D, Yang H, Jimmy SD, Duncan B, et al. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia 2009;50:1141-9.
DOI
ScienceOn
|
13 |
Vaisleib II, Neft RA. Rapid dosge titration of levetiracetam in children. Pharmacotherapy 2008;28:393-6.
DOI
ScienceOn
|
14 |
Kossoff EH, Los JG, Boatman DF. A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy. Epilepsy & Behavior 2007;11:514-7.
DOI
ScienceOn
|
15 |
Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Glauer LJ, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006;66:1654-60.
DOI
ScienceOn
|
16 |
Grosso S, Cordelli DM, Franzoni E, Coppola G, Capovilla G, Zamponi N, et al. Efficacy and safty of levetiracetam in infants and young children with refractory epilepsy. Seizure 2007;16:345-50.
DOI
ScienceOn
|
17 |
Glauser TA, Pellock JM, Bebin EM. Efficacy and safty of levetiracetam in children with partial seizures: An open-lavel trial. Epilepsia 2002;43:518-24.
DOI
ScienceOn
|
18 |
Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, et al. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Developmental medicine & child neurology 2008;50:29-32.
|
19 |
Goraya JS, Khurana DS, Valencia I, Melvin JJ, Cruz M, Legido A, et al. Intravenous levetiracetam in children with epilepsy. Pediatr Neurol 2008;38;177-80.
DOI
ScienceOn
|
20 |
Bourgeois BFD, Holder DL, Valencia I. Open-label assesment of levetiracetam efficacy and adverse effects in a pediatric population. Epilepsia 2001;42:53-4.
|
21 |
Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007;69:1751-60.
|
22 |
Radtke RA. Pharmacokinetics of levetiracetam. Epilepsia. 2001;42;24-7.
|
23 |
Opp J, Tuxhorn I, May T, Kluger G, Wiemer-Kruel A, Kurlemann G, et al. Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany. Seizure 2005;14:476-84.
DOI
ScienceOn
|
24 |
Park JS, Kang HC, You SJ. Clinical experience with levetiracetam adjunctive therapy for pediatric intractable epilepsy. J Korean Child Neurol Soc 2008;16:36-41.
|
25 |
Pellock JM, Glauser TA, Bebin EM. Pharmacokinetic study of levetiracetam in children. Epilepsia 2001;42:1574-9.
|
26 |
Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, et al. Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Epilepsia 2007;48:1117- 22.
DOI
ScienceOn
|
27 |
Berg AT, Kelly MM. Defining intractability: comparisons among published definitions. Epilepsia 2006;47:431-6.
DOI
ScienceOn
|
28 |
Lagae L, Buyse G, Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and monotherapy trial. Seizure 2005;14:66-71.
DOI
ScienceOn
|